Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
AbbVie Inc. (ABBV)
Market Closed
10 Aug, 20:00
NYSE
All
(13)
DE
(5)
AT
(1)
CL
(1)
MX
(1)
IT
(2)
GB
(2)
US
(1)
NYSE
Primary
LSE
XETRA
XFRA
XDUS
XMUN
XSTU
XMIL
XWBO
XMEX
XMIL
XSGO
CBOE
$
247.
97
+1.93
+0.7844%
$
434.7B
Market Cap
42.2
P/E Ratio
1.58%
Div Yield
4.21M
Volume
10.28
Eps
$
246.04
Previous Close
Investors:
TJD
DI
LC
+1426
Analysts:
TH
Watching
Watch
Add Transaction
Day Range
244.03
248.01
Year Range
190.75
267.47
Want to track
ABBV
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Statistics
News
Historical Data
Investors
Analysts
AbbVie Inc. (ABBV) Statistics
Valuation metrics
Market Cap
434.7B
Enterprise value
498.95B
Trailing P/E (ttm)
69.32
Forward P/E
12.96
PEG ratio
1.02
Price/Sales (ttm)
6.75
Price/Book (mrq)
-73.42
Enterprise Value/Revenue
7.75
Enterprise Value/EBITDA
25.85
Overview
Shares outstanding
1.77B
Float
1.76B
Shares short
20.91M
% Held by insiders
0%
% Held by institutions
0.77%
Average volume (10 days)
5.56M
Average volume (90 days)
7.08M
Price summary
52-Week low
190.75
52-Week high
267.47
Beta
0.3
50-Day moving average
251.46
200-Day moving average
222.2
Dividends and splits
Forward annual dividend rate
6.92
Forward annual dividend yield
0.0323%
Trailing annual dividend rate
6.83
Trailing annual dividend yield
0.0278%
5-Year annual dividend yield
3.62%
Payout ratio
1.9
Dividend Date
15 May 2026
Ex-Dividend Date
15 Apr 2026
Last split factor
-
Last split Date
-
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.1%
Operating margin
0.3%
Operational effectiveness
Return on assets
0.05%
Return on equity
-1.37%
Income Statement
Revenue (ttm)
62.82B
Revenue per share (ttm)
36.36
Quarterly revenue growth (yoy)
0.12%
Gross profit (ttm)
45.25B
EBITDA
22.7B
Net income to common (ttm)
3.6B
Diluted EPS (ttm)
3.57
Quarterly earnings growth (yoy)
-0.46%
Balance Sheet
Total cash (mrq)
9.39B
Total cash per share (mrq)
3.71
Total debt (mrq)
72.91B
Total Debt/Equity (mrq)
-11.93
Current ratio (mrq)
0.81%
Book value per share (mrq)
-3.31
Cash Flow
Cash flow statement
21.22B
Levered free cash flow (LFCF)
20.81B